Effects of N-acetylcysteine, oral glutathione (GSH) and a novel sublingual form of GSH on oxidative stress markers: A comparative crossover study.

Redox Biology

Volumn 6, Issue , 2015, Pages 198-205

  Schmitt, Bernard ^a   Vicenzi, Morgane ^b   Garrel, Catherine ^c   Denis, Frédéric M ^b  

^a Centre Hospitalier de Bretagne Sud   (France)

^b Laboratoires Le Stum   (France)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Dietary supplement; Glutathione; Metabolic syndrome; N acetyl cysteine; Nutraceuticals; Oral bioavailability; Oxidative stress; Sublingual

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; GLUTATHIONE; ANTIOXIDANT; BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TABLET; TRIACYLGLYCEROL;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG SAFETY; FEMALE; HUMAN; LIPID COMPOSITION; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VITAMIN BLOOD LEVEL; BIOAVAILABILITY; BLOOD; BLOOD PRESSURE; BODY MASS; DIET THERAPY; DIETARY SUPPLEMENT; DRUG EFFECTS; METABOLIC SYNDROME X; METABOLISM; ORAL DRUG ADMINISTRATION; PATHOLOGY; TABLET;

ACETYLCYSTEINE; ADMINISTRATION, ORAL; ANTIOXIDANTS; BIOLOGICAL AVAILABILITY; BIOMARKERS; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; FEMALE; GLUTATHIONE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OXIDATIVE STRESS; TABLETS; TRIGLYCERIDES; VITAMIN E;

EID: 84938890732     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2015.07.012     Document Type: Article

References (35)

1. Meister A., Anderson M.E. Glutathione. Annu. Rev. Biochem. 1983, 52:711-760.
2. Jones D.P. Redefining oxidative stress. Antioxid. Redox Signal. 2006, 8:1865-1879.
3. Fang Y.-Z., Yang S., Wu G. Free radicals, antioxidants, and nutrition. Nutrition 2002, 18:872-879.
4. Ketterer B., Coles B., Meyer D.J. The role of glutathione in detoxication. Environ. Health Perspect. 1983, 49:59-69.
5. Sen C.K. Redox signaling and the emerging therapeutic potential of thiol antioxidants. Biochem. Pharmacol. 1998, 55:1747-1758.
6. Meister A. Glutathione, ascorbate, and cellular protection. Cancer Res. 1994, 54:1969s-1975s.
7. Cruz R., Almaguer Melian W., Bergado Rosado J.A. Glutathione in cognitive function and neurodegeneration. Rev. Neurol. 2003, 36:877-886.
8. Smeyne M., Smeyne R.J. Glutathione metabolism and Parkinson's disease. Free Radic. Biol. Med. 2013, 62:13-25.
9. Gul M., Kutay F.Z., Temocin S., Hanninen O. Cellular and clinical implications of glutathione. Indian J. Exp. Biol. 2000, 38:625-634.
10. Loguercio C., Taranto D., Vitale L.M., Beneduce F., Del Vecchio Blanco C. Effect of liver cirrhosis and age on the glutathione concentration in the plasma, erythrocytes, and gastric mucosa of man. Free Radic. Biol. Med. 1996, 20:483-488.
11. Herzenberg L.A., De Rosa S.C., Dubs J.G., Roederer M., Anderson M.T., Ela S.W., Deresinski S.C., Herzenberg L.A. Glutathione deficiency is associated with impaired survival in HIV disease. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:1967-1972.
12. Giugliano D., Ceriello A., Paolisso G. Diabetes mellitus, hypertension, and cardiovascular disease: which role for oxidative stress?. Metabolism 1995, 44:363-368.
13. Usal A., Acartürk E., Yüregir G.T., Unlükurt I., Demirci C., Kurt H.I., Birand A. Decreased glutathione levels in acute myocardial infarction. Jpn. Heart J. 1996, 37:177-182.
14. Viña J., Sastre J., Anton V., Bruseghini L., Esteras A., Asensi M. Effect of aging on glutathione metabolism. Protection by antioxidants. EXS 1992, 62:136-144.
15. Jones D.P., Mody V.C., Carlson J.L., Lynn M.J., Sternberg P. Redox analysis of human plasma allows separation of pro-oxidant events of aging from decline in antioxidant defenses. Free Radic. Biol. Med. 2002, 33:1290-1300.
16. Zhang H., Forman H.J., Choi J. Gamma-glutamyl transpeptidase in glutathione biosynthesis. Methods Enzymol. 2005, 401:468-483.
17. Furukawa T., Meydani S.N., Blumberg J.B. Reversal of age-associated decline in immune responsiveness by dietary glutathione supplementation in mice. Mech. Ageing Dev. 1987, 38:107-117.
18. Schwartz J.L., Shklar G. Glutathione inhibits experimental oral carcinogenesis, p53 expression, and angiogenesis. Nutr. Cancer 1996, 26:229-236.
19. Kim S.J., Han D., Ahn B.H., Rhee J.S. Effect of glutathione, catechin, and epicatechin on the survival of Drosophila melanogaster under paraquat treatment. Biosci. Biotechnol. Biochem. 1997, 61:225-229.
20. Allen J., Bradley R.D. Effects of oral glutathione supplementation on systemic oxidative stress biomarkers in human volunteers. J. Altern. Complement. Med. 2011, 17:827-833.
21. Witschi A., Reddy S., Stofer B., Lauterburg B.H. The systemic availability of oral glutathione. Eur. J. Clin. Pharmacol. 1992, 43:667-669.
22. Atkuri K.R., Mantovani J.J., Herzenberg L.A., Herzenberg L.A. N-Acetylcysteine-a safe antidote for cysteine/glutathione deficiency. Curr. Opin. Pharmacol. 2007, 7:355-359.
23. A.T.P. III At-A-Glance: Quick Desk Reference-NHLBI, NIH. (accessed Feb 18, 2015). http://www.nhlbi.nih.gov/health-pro/guidelines/current/cholesterol-guidelines/quick-desk-reference-html.
24. McPherson R.A., Hardy G. Cysteine: the Fun-Ke nutraceutical. Nutrition 2012, 28:336-337.
25. Akerboom T.P., Sies H. Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples. Methods Enzymol. 1981, 77:373-382.
26. Ellman G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959, 82:70-77.
27. Riddles P.W., Blakeley R.L., Zerner B. Reassessment of Ellman's reagent. Methods Enzymol. 1983, 91:49-60.
28. Handelman G.J., Machlin L.J., Fitch K., Weiter J.J., Dratz E.A. Oral alpha-tocopherol supplements decrease plasma gamma-tocopherol levels in humans. J. Nutr. 1985, 115:807-813.
29. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972, 18:499-502.
30. Moher D., Hopewell S., Schulz K.F., Montori V., Gøtzsche P.C., Devereaux P.J., Elbourne D., Egger M., Altman D.G. CONSORT CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int. J. Surg. 2012, 10:28-55.
31. Bartoli G.M., Sies H. Reduced and oxidized glutathione efflux from liver. FEBS Lett. 1978, 86:89-91.
32. Li X., Qu Z.C., May J.M. GSH is required to recycle ascorbic acid in cultured liver cell lines. Antioxid. Redox Signal. 2001, 3:1089-1097.
33. Montecinos V., Guzmán P., Barra V., Villagrán M., Muñoz-Montesino C., Sotomayor K., Escobar E., Godoy A., Mardones L., Sotomayor P., Guzmán C., Vásquez O., Gallardo V., van Zundert B., Bono M.R., Oñate S.A., Bustamante M., Cárcamo J.G., Rivas C.I., Vera J.C. Vitamin C is an essential antioxidant that enhances survival of oxidatively stressed human vascular endothelial cells in the presence of a vast molar excess of glutathione. J. Biol. Chem. 2007, 282:15506-15515.
34. Halpner A.D., Handelman G.J., Harris J.M., Belmont C.A., Blumberg J.B. Protection by vitamin C of loss of vitamin E in cultured rat hepatocytes. Arch. Biochem. Biophys. 1998, 359:305-309.
35. Rushworth G.F., Megson I.L. Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits. Pharmacol. Ther. 2014, 141:150-159.